1
项与 Autologous dendritic cell vaccine(The Rockefeller University) 相关的临床试验A Phase I/II Study of Autologous Dendritic Cells Pulsed With Apoptotic Tumor Cells (DC/PC3) Administered Subcutaneously to Prostate Cancer Patients.
The purpose of this study is to assess the safety and activity of DC/PC3, a dendritic cell vaccine used as immunotherapy for prostate cancer. The vaccine is made with each participants' own immune cells obtained through blood donation. Dendritic cells are known to activate other immune cells such as T cells, that are able to mount an attack against cancer cells. The dendritic cell vaccine will be administered as injections every 2 weeks over a course of 2 months.
100 项与 Autologous dendritic cell vaccine(The Rockefeller University) 相关的临床结果
100 项与 Autologous dendritic cell vaccine(The Rockefeller University) 相关的转化医学
100 项与 Autologous dendritic cell vaccine(The Rockefeller University) 相关的专利(医药)
100 项与 Autologous dendritic cell vaccine(The Rockefeller University) 相关的药物交易